ClinicalTrials.Veeva

Menu

COVID-19 Serologies Among Healthcare Workers at CHSD (SERO2)

C

Centre Hospitalier de Saint-Denis

Status

Completed

Conditions

Antibodies, Viral
COVID-19
COVID-19 Serological Testing
Health Personnel
COVID-19 Vaccines
Seroepidemiologic Studies

Study type

Observational

Funder types

Other

Identifiers

NCT06989307
0011_SMIT

Details and patient eligibility

About

This study looks at how many healthcare workers at CHSD hospital developed antibodies against COVID-19 after the second and third waves of the pandemic and after receiving a vaccine. It aims to better understand who might still be at risk of infection, how long immunity lasts after getting COVID or the vaccine, and how reliable previous antibody tests were. Blood samples will be collected from volunteer hospital staff during a one-month period to measure their antibody levels and compare them to earlier results.

Enrollment

447 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Volunteers from the hospital staff who have signed a new informed consent form

Exclusion criteria

  • Refusal to participate (no signed consent form)
  • Staff unavailable during the blood sampling period
  • Participation only in the first seroprevalence survey without consent for the second

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems